Amphetamine-like stimulant remains in dietary supplements 2 years after FDA discovery

Amphetamine-like stimulant remains in dietary supplements 2 years after FDA discovery.

Amphetamine-like stimulant remains in dietary supplements 2 years after FDA discovery

At the same time, modafinil increases the level of histamine of the hypothalamus, which encouraged some researchers to consider modafinil as "a remedy for drowsiness" than a classical amphetamine-like stimulant.

On top of that, Modafinil elevates the level of histamine of the hypothalamus, which made certain scientists classify the formulation as "a remedy for drowsiness" rather than a classic amphetamine-like stimulant.

However, modafinil increases hypothalamic histamine levels, which made some researchers consider modafinil “a drug against insomnia” rather than a classic amphetamine-like stimulant.

In January 2014, the US Food and Drug Administration published a study in which they identified an amphetamine-like stimulant in a number of commonly used dietary supplements.